Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Jun;34(6):781-782.
doi: 10.1007/s11606-019-04938-3.

N-of-1 Trials in Hypertension Are Feasible, but Are They Worthwhile?

Richard L Kravitz  1
Affiliations
Editorial

N-of-1 Trials in Hypertension Are Feasible, but Are They Worthwhile?

Richard L Kravitz. J Gen Intern Med. 2019 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The author reports no relevant conflicts of interest.

References

    1. Kent DM, Steyerberg E, van Klaveren D. Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects. BMJ. 2018;363:k4245. doi: 10.1136/bmj.k4245. - DOI - PMC - PubMed
    1. Lovallo D, Kahneman D. Delusions of success. How optimism undermines executives' decisions. Harv Bus Rev. 2003;81(7):56–63, 117. - PubMed
    1. Duan N, Kravitz RL, Schmid CH. Single-patient (n-of-1) trials: a pragmatic clinical decision methodology for patient-centered comparative effectiveness research. J Clin Epidemiol. 2013;66(8 Suppl):S21–28. - PMC - PubMed
    1. Zucker DR, Ruthazer R, Schmid CH, et al. Lessons learned combining N-of-1 trials to assess fibromyalgia therapies. J Rheumatol. 2006;33(10):2069–2077. - PubMed
    1. Guyatt G, Sackett D, Taylor DW, Chong J, Roberts R, Pugsley S. Determining optimal therapy--randomized trials in individual patients. N Engl J Med. 1986;314(14):889–892. doi: 10.1056/NEJM198604033141406. - DOI - PubMed

Publication types

LinkOut - more resources